Nexeon Medsystems and QT Imaging Compared in Financial Survey

Analysis of medical device companies Nexeon Medsystems and QT Imaging reveals differences in volatility, revenue, and analyst recommendations.

Published on Mar. 10, 2026

Got story updates? Submit your updates here. ›

A financial survey compares two medical device companies, Nexeon Medsystems and QT Imaging, to determine which is the better business. The analysis looks at factors like risk, profitability, earnings, dividends, institutional ownership, analyst recommendations, and valuation.

Why it matters

This comparison provides investors with insights into the relative strengths and weaknesses of these two medical technology firms, which could inform investment decisions and highlight key industry trends.

The details

The survey finds that Nexeon Medsystems has higher earnings but lower revenue than QT Imaging. Nexeon also has much higher volatility, with a beta of 6.98 compared to QT Imaging's -0.11. However, Nexeon has stronger insider ownership at 61.2% versus 28.8% for QT Imaging. Analysts are more bullish on Nexeon, with more "buy" ratings compared to QT Imaging.

  • The financial survey was published on March 10, 2026.

The players

Nexeon Medsystems Inc.

A medical device company that develops, manufactures, and commercializes neurostimulation technology for treating various neurological disorders.

QT Imaging Holdings, Inc.

A company that researches, develops, and commercializes body imaging systems for detecting, diagnosing, monitoring, and treating diseases, including its QT Ultrasound Breast Scanner.

Got photos? Submit your photos here. ›

The takeaway

This analysis highlights the differing risk profiles, financial performance, and analyst perceptions of these two medical technology firms, providing investors with valuable information to consider when evaluating potential investments in the sector.